Neidig Brent 4

What Happened
Brent Neidig, Chief Commercial Officer of USANA Health Sciences (USNA), was granted 37,610 restricted stock units (RSUs) on February 19, 2026. The grant is reported as a derivative award at $0.00 per unit (no cash purchase); each RSU represents a contingent right to receive one share of USNA common stock upon vesting.

Key Details

• Transaction date: 2026-02-19; Form 4 filed: 2026-02-23 (the filing reports the Feb 19 grant).
• Grant size: 37,610 RSUs; reported acquisition price per unit: $0.00 (derivative award).
• Vesting: 25% vests on each February 19 thereafter (per filing footnote).
• Footnotes: F1 — each RSU equals a contingent right to one share; F2 — vesting schedule as stated above.
• Shares owned after transaction: not specified in the provided filing summary.
• Timeliness: Form 4 filed Feb 23 reporting a Feb 19 grant; no late-filing flag was noted in the provided data.

Context
This was an equity compensation grant (award), not a market purchase or sale. RSU awards are commonly used for retention and long-term incentive; they do not represent immediate selling or buying pressure until shares vest and are delivered. For retail investors, grants signal executive compensation alignment with shareholders but do not on their own indicate a change in the insider’s view on the stock.